RT Journal Article
SR Electronic
T1 Likelihood based Mendelian randomization analysis with automated instrument selection and horizontal pleiotropic modeling
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.11.03.21265848
DO 10.1101/2021.11.03.21265848
A1 Yuan, Zhongshang
A1 Liu, Lu
A1 Guo, Ping
A1 Yan, Ran
A1 Xue, Fuzhong
A1 Zhou, Xiang
YR 2021
UL http://medrxiv.org/content/early/2021/12/22/2021.11.03.21265848.abstract
AB Mendelian randomization (MR) is a common tool for identifying causal risk factors underlying diseases. Here, we present a method, MRAID, for effective MR analysis. MRAID borrows ideas from fine mapping analysis to model an initial set of candidate SNPs that are in potentially high linkage disequilibrium with each other and automatically selects among them the suitable instruments for causal inference. MRAID also explicitly models both uncorrelated and correlated horizontal pleiotropic effects that are widespread for complex trait analysis. MRAID achieves both tasks through a joint likelihood framework and relies on a scalable sampling-based algorithm to compute calibrated p-values. Comprehensive and realistic simulations show MRAID can provide calibrated type I error control, reduce false positives, while being more powerful than existing approaches. We illustrate the benefits of MRAID for an MR screening analysis across 645 trait pairs in UK Biobank, identifying multiple lifestyle causal risk factors of cardiovascular disease-related traits.Competing Interest StatementThe authors have declared no competing interest.Funding StatementZY was supported by the National Natural Science Foundation of China (81872712), the Natural Science Foundation of Shandong Province (ZR2019ZD02) and the Young Scholars Program of Shandong University (2016WLJH23). XZ was supported by the University of Michigan. This study has been conducted using UK Biobank resource under Application Number 51470. UK Biobank was established by the Wellcome Trust medical charity, Medical Research Council, Department of Health, Scottish Government and the Northwest Regional Development Agency. It also has funding from the Welsh Assembly Government, British Heart Foundation and Diabetes UK.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced are available online at https://www.ukbiobank.ac.uk/. https://www.ukbiobank.ac.uk/